MedPath

A study to compare injection and oral formulation of a drug ondansetron to manage children suffering from diarrhea and vomiting

Not Applicable
Completed
Conditions
Health Condition 1: E860- DehydrationHealth Condition 2: R197- Diarrhea, unspecifiedHealth Condition 3: R111- Vomiting
Registration Number
CTRI/2020/01/023082
Lead Sponsor
niversity College of Medical Sciences and GTB Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Children with acute diarrhea (duration <14 days) with some dehydration as per WHO criteria, and at least two reported episodes of non-bilious, non-bloody, vomiting within last 6 hours

Exclusion Criteria

1. Severe malnutrition (weight for length / height <â??3 SD of WHO standard)

2. Conditions associated with edema (e.g. nephrotic syndrome, congestive heart failure)

3. Known hypersensitivity to ondansetron

4. Known cardiac disorder or previous history of arrhythmias

5. Unconscious or Convulsing

6. Presence of paralytic ileus or intestinal obstruction as evaluated clinically.

7. Children who have received any antiemetic or intravenous fluids within 24 hours before enrolment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath